書誌事項
- タイトル別名
-
- Antibacterial activity of gemifloxacin against clinical isolates
この論文をさがす
抄録
In vitro antibacterial activity of gemifloxacin, a new fluoro quinolone agent, and other drugs was determined against clinical isolates in 2005 Japan and clinical isolates of levofloxacin-resistant Streptococcus pneumoniae after 2003.<BR>Gemifloxacin MIC90 was 0.031μg/mL, higher than other fluoro quinolone agents. Gemifloxacin activity is good in levofloxacin-resistant S. pneumoniae because gemifloxacin MIC90 of levofloxacin-resistant Streptococcus pneumoniae was 0.5μg/mL, higher than other fluoro quinolone agents. Gemifloxacin MIC90 against Haernophilus influenzae was 0.015μg/mL. Gemifloxacin MIC90 against ampicillin-resistant β-lactamase negative Haemophilus influenzae (BLNAR) was 0.063μg/mle. Gemifloxacin MIC90 against methicillin-resistant Staphylococcus aureus was low the same as for other fluoro quinolone agents. Gemifloxacin activity was shown in Moraxella (Branhamella) catarrhalis, Kiebsiella pneumoniae, and Pseudomonas aeruginosa similar to other fluoro-quinolone agents. Our results suggest that gemifloxacin effective clinical respiratory organ infectious disease treatment.
収録刊行物
-
- 日本化学療法学会雑誌
-
日本化学療法学会雑誌 56 (1), 16-20, 2008
公益社団法人 日本化学療法学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001206284260224
-
- NII論文ID
- 130004298356
- 10020179266
-
- NII書誌ID
- AN10472127
-
- ISSN
- 18845886
- 13407007
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可